# Blood & Lymphoreticular System
## Infectious and immunologic, including microbiologic and host response to insult
### infectious disorders
#### bacterial
#### viral: hemorrhagic fever (Ebola virus, Marburg virus); chikungunya; dengue fever; Zika virus disease
#### parasitic: malaria (Plasmodium species); babesiosis (Babesia species)
### primary infections of lymphoid tissue
#### lymphadenitis (viral, bacterial, fungal, parasitic); lymphangitis; buboes, bubonic plague (Yersinia pestis); cat-scratch disease (Bartonella henselae)
### immunologic and inflammatory disorders
#### cryoglobulinemia, essential mixed cryoglobulinemia; autoimmune hemolytic anemia; paroxysmal nocturnal hemoglobinuria; thrombotic thrombocytopenic purpura; hemolytic uremic syndrome
## Neoplasms
### leukemia, acute (ALL, AML); leukemia, chronic (CLL, CML); lymphomas, Hodgkin disease, non-Hodgkin lymphoma, Burkitt lymphoma, T-cell lymphoma; multiple myeloma, dysproteinemias, monoclonal gammopathy of unknown significance (MGUS); myelofibrosis; myelodysplastic syndrome, myelodysplasias; other immunoproliferative neoplasms (eg, Waldenstrom macroglobulinemia)
## Anemia, cytopenias, and polycythemia anemias
### decreased production
#### anemia of chronic disease
### hemolysis
#### glucose 6-phosphate dehydrogenase deficiency; pyruvate kinase deficiency
### disorders of hemoglobin, heme, or membrane
#### disorders of red cell membranes; hereditary spherocytosis, elliptocytosis; methemoglobinemia, congenital; sickle cell disease; sideroblastic anemia; thalassemias
### other causes of anemia
#### blood loss, acute and chronic as a cause of anemia
### cytopenias
#### aplastic anemia; leukopenia; neutropenia, cyclic neutropenia, agranulocytosis; pancytopenia; thrombocytopenia, quantitative; immune thrombocytopenic purpura (ITP)
### cythemias
#### leukocytosis; polycythemia vera; secondary polycythemia
## Coagulation disorders (hypocoagulable and hypercoagulable conditions)
### hypocoagulable
#### disseminated intravascular coagulation; hemophilia, congenital; factors VIII [hemophilia A] and IX [hemophilia B]; hypofibrinogenemia; von Willebrand disease; platelet dysfunction, qualitative
### hypercoagulable
#### heparin-induced thrombocytopenia; other coagulopathies (eg, homocysteinemia, hypoplasminogenemia, antithrombin III, protein C/protein S deficiency, Factor V Leiden, anticardiolipin antibodies, lupus anticoagulant, prothrombin G20210A mutation)
### reactions to blood components
#### ABO incompatibility/anaphylaxis; Rh incompatibility/anaphylaxis; hemolysis, delayed; transfusion reaction; transfusion contaminated with bacteria; transfusion-related acute lung injury (TRALI); anaphylactoid reaction (IgA deficiency)
## Traumatic, mechanical, and vascular disorders
### mechanical injury to erythrocytes (eg, cardiac valve hemolysis)
### disorders of the spleen
#### splenic rupture/laceration; splenic infarct; splenic abscess; effects/complications of splenectomy (eg, sepsis due to encapsulated bacteria); hypersplenism
## Adverse effects of drugs on the hematologic and lymphoreticular systems
### antiplatelet drugs; antithrombin drugs (eg, dabigatran); chemotherapeutic agents; inhibitors of coagulation factors; methemoglobinemia, acquired; propylthiouracil; tumor lysis syndrome; warfarin
